Latest filing published 06 Feb 2019 for Regulus Therapeutics Inc., €33k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Timothy Michael Wright: trading record in brief
Timothy Michael Wright appears in our data through filings on Regulus Therapeutics Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 25 July 2017 and the latest from 5 February 2019.
Purchases make up the whole of the open-market record (1 purchase, €215k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant.
Most recently, on 6 February 2019, the filings show a share grant worth €33k in Regulus Therapeutics Inc. The most recent open-market purchase was published on 25 July 2017, 3,394 days ago. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Timothy Michael Wright
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 40,000 shares@ US$0.95100.0% of flowCommon StockSEC:0001209191-19-007778:0
- 274,725 shares@ US$0.9186.6% of flowCommon StockSEC:0001209191-17-046235:0Canonical exit: 23 Oct 2017 (T+90)
2 of 2 declarations
